Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 July, 2018 08:12 IST
Alembic Pharma receives USFDA tentative approval for lloperidone Tablets
Source: IRIS | 12 Jul, 2018, 10.46AM
Comments  |  Post Comment

Alembic Pharmaceuticals Wednesday announced that the company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for lloperidone tablets, 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg.

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Fanapt Tablets, 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg, of Vanda Pharmaceuticals, Inc. lloperidone tablets are indicated for the treatment of schizophrenia inadults.

lloperidone Tablets have an estimated market size of US$ 128 million for twelve months ending December 2017 according to IQVIA.

Alembic now has a total of 74 ANDA approvals (65 final approvals and 9 tentative approvals) from USFDA.

Shares of the company gained Rs 7.1, or 1.34%, to trade at Rs 538.00. The total volume of shares traded was 708 at the BSE (10.33 a.m., Thursday).



Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Infosys Q1 profit rises 4% y-o-y to Rs 36.12 bn - 13-Jul-2018 16:45
Rise in India's crude oil imports, driven by increased consumption: Ind-Ra - 13-Jul-2018 10:44
India's retail sales will cross USD 1.24 trn by 2018: Study - 13-Jul-2018 10:01
White Organic Agro receives export order for 65 MT of cluster beans - 13-Jul-2018 09:51
Vakrangee partners with Reliance Nippon Life Asset Management - 13-Jul-2018 09:47
Larsen & Toubro wins orders worth Rs 30 bn - 13-Jul-2018 09:41
Dilip Buildcon incorporates SPV for Rs 13.13 bn NHAI road project - 12-Jul-2018 15:41
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA - 12-Jul-2018 13:23
Lupin receives nod for generic Nitrofurantoin capsules - 12-Jul-2018 12:39
Aban Offshore receives LoA for deployment of 3 jack-up rigs in UAE - 12-Jul-2018 12:26
Sun Pharma arm Dusa files lawsuit against Biofrontera - 12-Jul-2018 11:01
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer